93 results
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
trials with the FDA ... EBM #Psychiatry #NegativeTrials ... Bias #Comparison #FDA
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
trials with the FDA ... EBM #Psychiatry #NegativeTrials ... Bias #Comparison #FDA
Trial of Solanezumab for Mild Dementia Due to Alzheimers Disease #EBM #Dementia #Solanezumab #Alzheimers #NegativeTrial #VisualAbstract
Solanezumab #Alzheimers #NegativeTrial
With the recent publication of the FDA Guidance on alcohol-based hand sanitizer compounding, I thought to
publication of the FDA ... with both the FDA ... FDA is also encouraging
History of Systemic Thrombolysis for Ischemic Stroke and Benefit in Neurologic Outcomes - Salim R. Rezaie
Neurology #Stroke #NegativeTrials
Thrombolytics for stroke: The evidence - 
A summary of the evidence for (or against) thrombolytics for
EBM #Neurology #NegativeTrials
Alprazolam - short-acting benzodiazepine (GABA Receptor Modulator) used in the treatment of anxiety disorders. FDA approved
FDA approved in
Elagolix (Orilissa) - Pharmacology Review
Elagolix is a small-molecule GnRH antagonist recently approved by the FDA for
approved by the FDA
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
FDA recommends, ... ADA/KDIGO Consensus ... Diabetes #CKD #ADA
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
approved by the FDA